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Historical Considerations and Semantics
In two recent publications, evidence was presented that
the endothelial cell of the mammalian liver sinusoid rep-
resents a special scavenger type of endothelial cells that is
found in all vertebrates [1,2]. These endothelial cells are
located in the liver of land-based vertebrates (mammals,
birds, reptiles, amphibians), in the heart or kidney of
bony fishes, and in the gill of cartilagenous fishes, lam-
prey and hagfish. In all animal species studied these spe-
cialized endothelial cells show an extraordinarily high
uptake of soluble waste macromolecules from the circula-
tion. On this basis the term "scavenger endothelial cell"
(SEC) was coined to highlight the biological function of
these cells. The first hint that these cells carry out an
important physiological function in the elimination of
waste material from the circulation was obtained in the
early 80s when it was shown for the first time that a phys-
iological waste macromolecule, hyaluronan (HA), was
avidly and specifically eliminated from the circulation of
rats, rabbits and humans in LSEC [3]. The finding that
SEC, but not Kupffer cells (KC) were responsible for this
RES function came as a surprise because the general
understanding at that time was that blood clearance of
material that is too large for glomerular filtration
(Mw>20.000) would be eliminated mainly by uptake in
KC, which were believed to make up the RES of the liver.
In the years that followed we and others showed that an
array of physiological and foreign soluble macromole-
cules and colloids were eliminated from the circulation
mainly by receptor-mediated pinocytosis almost exclu-
sively in LSEC. Experiments in other vertebrates, in partic-
ular the most numerous class, namely bony fishes, have
shown that the specificity and mode of uptake is remark-
ably similar among vertebrates of considerably different
phylogenetic age. This finding further justifies the use of
the common term SEC to describe these cells in all verte-
brates.
To conceive the significance of SEC it is essential to under-
stand the meaning of RES. Clearly, the meaning of RES
has changed from when it was first launched by Aschoff
[4] in 1924 and until today. A major finding that lead
Aschoff to his conclusions was the numerous studies by
him and others showing that vital stains are taken up in
certain cells of the body. Another very important finding
that contributed to the proposal of RES was Metchnikoff's
discovery of phagocytosis in macrophages about 30 years
prior to Aschoff's RES-publication [5].
Metchnikoff's introduction of phagocytosis as a means for
cells to take up material from their surroundings offered a
way to explain how vital stain was taken up in cells of RES.
It should be noted here that Metchnikoff used the term
phagocytosis to describe uptake of both large particles and
soluble material such as the vital stain carmin. Today we
distinguish between phagocytosis and pinocytosis. Phagocy-
tosis denotes cell eating or uptake of large particles
(roughly 1 micrometer and greater), and is mainly associ-
ated with the function of the macrophages, also called
"professional phagocytes." Pinocytosis, or cell drinking,
denotes cellular uptake of soluble material (macromole-
cules and colloids smaller than 100 nm). Present-day text-
books in cell biology use the concept of receptor-
mediated endocytosis as a special form of pinocytosis
("clathrin-mediated or coated pit-mediated pinocytosis").
When we use these terms today, most of us are unaware of
the fact that the concept of pinocytosis was introduced as
late as in 1931 [6].
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Thus, phagocytosis was the only term available to biologists
to describe cellular uptake during the period from Metch-
nikoff until 1931. When Aschoff published his paper on
RES in 1924 [4] it would take another decade before the
concept of pinocytosis was introduced. Even after the
introduction of "pinocytosis" and till the present time
many scientists use the word phagocytosis to erroneously
describe any type of endocytic uptake, including pinocy-
tosis. The type of pinocytosis that prevails in SEC is recep-
tor-mediated endocytosis via clathrin coated pits. In fact,
since SEC are probably the most active pinocytic cell in
the vertebrate body it deserves the nick-name "profes-
sional pinocyte" for the same reason that macrophages are
referred to as "professional phagocytes". Reasoning that
uptake in RES is exclusively mediated by phagocytosis,
just like most of his contemporary colleagues, van Furth
[7] in 1972 recommended that RES be removed from the
vocabulary and replaced completely by the mononuclear
phagocyte, or "macrophage" system (MPS). This recom-
mendation obscured our ability to discover and under-
stand that Aschoff's RES consisted of non-macrophagic,
non-phagocytic cells in addition to macrophages. In fact,
if the hepatic RES be defined strictly on the basis of distri-
bution of i.v. injected vital stain, as recommended by
Aschoff, pinocytosis in SEC would play a far more impor-
tant role than phagocytosis in KC in the hepatic RES.
Using modern methods of identifying the different types
of liver sinusoidal cells, combined with the original vital
stain method, Kawai, et al. [8], showed that lithium car-
mine, the most widely used vital stain among the early
RES researchers, was taken up mostly by the LSEC of rat.
The lesson to be learned from this historical and semantic
survey is that RES of vertebrates consists of two major cell
types, namely the macrophage, which eliminates particles
from the circulation via phagocytosis, and the SEC, that
removes soluble macromolecules via a non-phagocytic
receptor-mediated endocytosis.
Scavenger Function of SEC
We know far more about mechanisms of synthesis of mac-
romolecules than the mechanisms of degradation. This is
surprising insofar as anabolism and catabolism are
equally important in a body at homeostasis. Moreover,
focusing more on synthesis than degradation has led
many researchers to underestimate the catabolic arm
when studying the turnover of proteins. For instance, in
liver fibrosis and some other disorders associated with a
higher synthesis of connective tissue molecules, it is com-
mon to interpret increased blood levels of these to reflect
increased synthesis, and therefore increased fibrotic activ-
ity. However, the discovery that LSEC represent the major
site of elimination of connective tissue molecules from
the circulation [9-14], revealed that increased blood con-
centrations of these substances reflect both the rate of syn-
thesis as well as their elimination in LSEC.
SEC can bind but not internalize particles via their 
endocytosis receptors
It has been shown that red blood cells coated with anti-
red cell IgG bind avidly to Fc-gamma receptors on both
KC and SEC of rat liver [15] (see section on Fc-gamma
receptors below). Interestingly, only KC subsequently
engulfed these particles, whereas no internalization was
observed in LSEC. In a study to compare binding and
internalization of free, soluble chains and particles (1
micrometer) of chondroitin sulphate (CS) it was found
that LSEC but not KC bound and internalized the soluble
form of CS. Although the CS particles bound to both KC
and LSEC, only KC were able to internalize them [16].
These two experiments clearly suggest that KC represent
the professional phagocyte, and LSEC the professional
pinocyte in the mammalian liver RES. This share of work
between macrophages and SEC has been found in animal
species of all vertebrate classes [2].
Colloids are cleared mainly by SEC
Colloids represent small particles (in the nm range) that
behave both as soluble macromolecules and particles.
Due to their small size, colloids are generally recognized
by cells as soluble matter, and consequently are pinocy-
tosed. We have observed that colloidal gold particles up to
at least 100 nm distribute almost exclusively to LSEC after
i.v. injection in rats (unpublished data). At variance from
colloidal gold, colloidal carbon, a substance that was fre-
quently used in the past to test the function of RES, is
taken up mainly by KC and other macrophages that are
exposed to the blood circulation [17]. This was for some
time interpreted as evidence that colloidal carbon is
phagocytosed by macrophages. A few authors at that time
warned that colloidal carbon binds to and activates plate-
lets, with the consequence that the accumulation of car-
bon in KC was due to phagocytosis of carbon-laden
aggregated platelets rather than uptake of free colloidal
carbon. The uptake of platelets due to carbon injection is
so active that transient thrombocytopenia has been
reported by some authors [18,19].
Endocytosis receptors in SEC and their macromolecular 
ligands
A surprisingly low number of receptors (defined accord-
ing to ligand specificity) are responsible for uptake of a
large number of different ligands. In mammals only 4 dif-
ferent receptors have been functionally observed in LSEC.
Moreover, studies carried out primarily in Atlantic cod
and salmon, but also in species from the other vertebrate
classes, have revealed that 3 of these receptors are present
on SEC of lower vertebrates [2]. Endocytosis receptors on
SEC and some of their physiologic ligands are described in
the next paragraphs.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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The collagen-alpha chain receptor (COLLA-R) was func-
tionally described for the first time in 1984 [9]. This recep-
tor recognizes only free alpha chains, but not native triple-
helical collagen, and is thus a receptor that mediates elim-
ination of collagen waste molecules resulting from physi-
ological collagenolysis. Although it is frequently thought
that collagen is a stable protein with a rather long half life,
this is not the case if one considers the overall turnover of
collagen in the body. In fact, several grams of collagen are
catabolized per day in a normal human body. Collagen
breakdown in the tissues starts with a single clip by verte-
brate collagenase, releasing two large pieces of the triple
helix. At body temperature these pieces are unstable,
resulting in the generation of free alpha chains. A fraction
of these collagen alpha chains is degraded locally, some is
sequestered in lymph nodes, and the fraction that finally
enters the circulation is efficiently endocytosed and
degraded by LSEC [20]. The COLLA-R has so far been
observed only in SEC. Studies in rat and cod have revealed
that the receptor does not distinguish between different
types or species origin of collagen [21]. Uptake studies in
animal species from all classes of vertebrates indicate the
presence of a COLLA-R in all vertebrate SEC [2]. Binding
studies in rat LSEC showed that each LSEC expresses 8 ×
104 receptors with Kd 1.3 × 10-9 and 3 × 105 receptors with
Kd 7.1 × 10-9 [10]. Work is under way in our laboratory to
characterize the molecular structure of the vertebrate SEC
COLLA-R. The physiological significance of this receptor
is obvious: it prevents accumulation of gelatin in the cir-
culation, thus preventing pathological conditions such as
autoimmunity and intravascular clotting.
The mannose-receptor (MANN-R)
Identical to the macrophage MANN-R, the MANN-R of
vertebrate SEC eliminates molecules rapidly from the cir-
culation by Ca++-dependent recognition of mannose resi-
dues at the terminus of glycoconjugates [22]. Although a
large number of both physiological and foreign ligands
for this receptor have been reported, I focus here on 3
important physiological waste macromolecules that are
cleared from the blood by MANN-R mediated uptake in
SEC: i) lysosomal enzymes [23], ii) tissue plasminogen
activator [24], and iii) carboxyterminal propeptides of
type I procollagen [13].
i) Lysosomal enzymes
SEC contain very high specific activities of lysosomal
enzymes; with some enzymes the activity is even higher in
LSEC than in KC [25]. This observation is compatible with
the notion that SEC are extremely active in uptake and
degradation of circulating waste products, and therefore
need high activities of acid hydrolases in their endosomal/
lysosomal apparatus. The high specific activities of lyso-
somal enzymes in SEC is explained by the fact that the
cells recruit these enzymes from the circulation [23]. Lys-
osomal enzymes are constantly being released to the cir-
culation as part of physiological processes. Since these
enzymes carry terminal mannose they are readily recog-
nized by the SEC MANN-R and internalized. However, at
variance from most other physiological macromolecules,
lysosomal enzymes are not readily degraded. They survive
the harsh catabolic milieu in the endosomal/lysosomal
compartment, and retain this feature even after they have
been captured by SEC. Experiments in rats showed that
more than 60% of i.v. injected 125I-labeled glycosylaspar-
aginase (GAG) was eliminated with a t1/2 of about 0.7
min, the remaining 40% being eliminated with a t1/2 of
approx. 3 min. The enzyme was cleared almost exclusively
by the LSEC. Circulatory survival was significantly pro-
longed when mannose was included in the injected bolus,
signifying uptake via the MANN-R. GAG was highly resist-
ant to degradation after uptake, 33% and 20% of the label
being detectable in liver after 1 and 2 days, respectively.
Studies with pure cultures of rat LSEC confirmed the in
vivo findings: GAG was endocytosed at a very high rate,
about 40% of added ligand being taken up in the cells
after only 60 min. of incubation. After 8 h of incubation
with 125I-GAG no degradation products could be detected.
After 24 h only 10% had been degraded. Endocytosis of
the enzyme in cultured LSEC was effectively competed for
by mannose. Determination of GAG activity in lysates of
LSEC showed that 1) the level of endogenous enzyme
decreased after 18 h of incubation in vitro, and 2) exoge-
nous enzyme was retained intact in LSEC after endocyto-
sis. Consequently, once captured by LSEC, GAG will carry
out its catabolic function in the acid intralysosomal envi-
ronment. Another lysosomal enzyme, alpha-mannosi-
dase, was found to be processed much the same way as
GAG in rat LSEC after endocytosis via the MANN-R
(unpublished data). Moreover, a recent study in the Atlan-
tic cod showed that circulating lysosomal cod alpha-man-
nosidase is removed largely by MANN-R mediated
endocytosis in SEC, transported to the lysosomes, and
reused there for a long time (days) [26]. A recent study
showed that the concentration of 8 different lysosomal
enzymes in the blood was several-fold higher in MANN-R
deficient mice compared to wild-type mice [27].
The high content of lysosomal enzymes in SEC may alter-
natively be explained by a very high de novo synthesis.
Newly synthesized lysosomal enzymes acquire mannose
6-phosphate (M6P) recognition signals that direct them
from the trans-Golgi network to the prelysosomal (late
endosomal) compartment. Two receptors, a small (46
kD) cation dependent-receptor and a large (300 kD) cat-
ion independent M6P receptor, have been shown to be
involved in this sorting function in mammalian cells.
Both receptors are required for efficient sorting of lyso-
somal enzymes [28]. This fact, combined with the obser-
vation that LSEC carry very low levels of the large M6PRComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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(unpublished data) support the notion that the cells do
not make significant amounts of lysosomal enzymes on
their own, which favors the hypothesis that they recruit
lysosomal enzymes from the circulation.
ii) Tissue plasminogen activator (tPA)
Lysis of a fibrin clot (fibrinolysis) is achieved by the active
enzyme plasmin obtained by activation of the proenzyme
plasminogen by plasminogen activators. The tissue type
plasminogen activator (tPA) binds specifically to fibrin,
and there increases its activity several-fold and activates
the powerful proteolytic enzyme plasmin only at the site
of clotting. We found that tPA is effectively endocytosed in
rat LSEC via the MANN-R [29]. Subsequent studies in vivo
and in vitro showed that tPA is cleared by a biphasic kinet-
ics: an initial rapid alpha-phase that removes 76% of
injected dose with a t1/2 = 0.5 min), and a slow beta-phase
that removes 24% of the injected dose with a t1/2 = 6.3
min). Competition studies provided evidence that the sig-
nals for uptake of tPA in LSEC are terminal mannose and
galactose, respectively, which are present in the carbohy-
drate side-chains of tPA [30-33]. Uptake via the LSEC
MANN-R was responsible for the rapid alpha-phase,
whereas the slower beta-phase was brought about by the
galactose, or asialoglycoprotein receptor of hepatocytes.
These studies reveal that the SEC MANN-R regulates the
fibrinolytic activity by removing blood-borne tPA.
iii) Carboxyterminal propeptide of type I procollagen (PICP)
Type I collagen is the most abundant collagen species in
many soft tissues and accounts for more than 90 per cent
of the organic matrix of mineralized bone. It is synthe-
sized in the form of a larger protein, type I procollagen,
which contains relatively long additional sequences at
both ends [34]. These sequences, known as the amino-
and carboxyterminal propeptides of type I procollagen,
are removed by two specific proteinases in the extracellu-
lar space. Proper cleavage of the precursor-specific parts of
the molecule is a prerequisite for the appropriate assem-
bly of type I collagen molecules into collagen fibers [35].
PICP contains covalently linked high-mannose type oli-
gosaccharide, one branch per polypeptide chain [36,37].
When PICP is cleaved off en block from the procollagen
molecule, it is found in free form in interstitial fluid, e.g.,
in healing wounds [38] and also in blood, where its con-
centration is regarded to reflect type I collagen synthesis in
the body, preferably in the skeleton [39]. However, for the
correct interpretation of the concentration of PICP in
blood it would also be essential to know the routes along
which this compound leaves the circulation. We have
shown that uptake of PICP is another function of the SEC
MANN-R [13]. The same conclusion was recently reached
by analyzing the serum protein profile of MANN-R knock-
out mice [27].
The hyaluronan/scavenger receptor (HA/S-R)
Studies on the turnover of the connective tissue polysac-
charide hyaluronan (HA) show that this substance is elim-
inated from the circulation almost exclusively by receptor-
mediated endocytosis in SEC of rat liver, salmon kidney,
and cod heart [2]. A series of experiments performed to
determine the exact specificity suggested that rat LSEC
express an endocytosis receptor with binding specificity
only for HA and the related connective tissue polysaccha-
ride chondroitin sulphate (CS) [40]. The affinity was cal-
culated to be rather high (Kd = 10-11 for HA of Mw 4 ×
105), and the number of receptors expressed per cell was
estimated to be about 8000 [40]. Both HA and CS are
highly negatively charged polymers, and it was speculated
that these molecules be recognized by the so-called scav-
enger receptor (SR), which is actually a group of different
endocytosis receptors with only one feature in common,
namely the ability to take up negatively charged macro-
molecules. To settle this question, receptor-ligand compe-
tition experiments were carried out to see if typical SR-
ligands were able to inhibit binding and uptake of HA and
CS. None of these experiments yielded results to support
that HA is taken up in SEC via the SR. However, in 1988
Eskild et al. [41] reported that formaldehyde-treated
serum albumin (FSA), a frequently used test ligand for the
SR, was able to inhibit the binding and uptake of free
chains of CS, but not HA in isolated rat LSEC. Curiously,
in cross competition experiments CS was unable to
inhibit uptake of FSA. Moreover, neither FSA nor HA com-
peted with each other for uptake. These findings left a hint
that the HA and SR were either the same protein or differ-
ent receptors with overlapping ligand specificities. It was
not until McCourt et al. in 1999 published their paper on
purification of the rat LSEC HA receptor [42] that the
enigma found its solution. These workers used affinity
purification, with either HA or aminoterminal propeptide
of type I procollagen (PINP), a protein that is cleared
exclusively by the SR of rat LSEC (10, and below), and
showed that a LSEC surface protein of identical Mw (~200
and ~350 kD) was purified irrespectively of whether HA
or PINP was used. Using antibodies generated against this
protein, it was possible to inhibit endocytosis of both HA,
and various SR-ligands [42]. The inability of a number of
SRs to inhibit endocytosis of HA was explained by bind-
ing affinity, which increases with the chain length of the
polysaccharide. The reason why Eskild et al. observed that
FSA inhibited CS but not HA [41] was most likely that the
CS chains used were short (only about 10–20 kd, which
would bind with an estimated Kd of 10-6 – 10-7), whereas
the HA chains were in the order of 106 d (with a Kd of
about 10-11). Thus, the binding of these short CS chains to
the receptor was relatively weak, whereas the binding
affinity of the much longer HA-chains was 4–5 orders of
magnitudes higher. Since the competing ligand, FSA,
bound to the receptor with a Kd of about 10-9, it wouldComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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compete strongly with CS, but not with HA for binding to
LSEC.
The SR function was discovered on macrophages, and has
been attributed to the accumulation of cholesterol-laden
modified LDL and thus initiate a series of inflammatory
events in the intima of the vessel wall, leading to athero-
sclerosis [43]. Today several SRs are known, many of
which have been characterized and cloned. The first SR to
be cloned was the macrophage SR, or SR-A [44]. This
receptor has been found on SEC, but reports showing that
transgenic mice lacking this receptor still remove SR-lig-
ands from the circulation as avidly as do wild-type mice,
suggest that these macromolecules are taken up from the
circulation by a different SR [45,46]. In fact, in vitro cul-
tures of SEC from SR-A knock out mice showed the same
uptake rate and capacity of endocytosis of several SR-lig-
ands [46]. These results, along with the recent characteri-
zation by McCourt et al. of the HA/S-R [[42], and
McCourt's article in this series of online proceedings],
show that LSEC, employing this unique receptor, repre-
sents the most important cellular site of uptake of blood-
borne SR-ligands. The mouse and human forms of HA/S-
R have now been cloned by Politz et al. [47] (Accession
nos. AF364951 and AJ295695) under the name Stabilin-2
(see also McCourt's article in the present proceedings).
It is unfortunate that the name "scavenger receptor" has
been taken to name exclusively this group of receptors.
When dealing with SEC it is obvious that both the
COLLA-R, MANN-R, and Fcgamma-R must be regarded as
different types of SRs. The term "scavenger receptor" has
no logical connection to the definition presently used
("the receptor that scavenges negatively charged macro-
molecules"). Semantically and logically it would be better
to associate "scavenger receptor" with any clearance recep-
tor that eliminates waste products. Thus, all endocytosis
receptors on SEC deserve the name "scavenger receptors".
In the following, I give two examples of categories of
waste substances that are eliminated by the SEC HA/S-R:
i) N-terminal propeptides of types I and III procollagen
(PINP and PIIINP), and ii) Atherogenic molecules: oxi-
dized LDL (oxLDL) and advanced glycation end products
(AGEs). Clearance of these substances represents an
important physiological mechanism contributing to
maintaining homeostasis, and preventing atherosclerosis.
i) Aminoterminal propeptides of types I and III collagen (PINP and 
PIIINP)
Collagen is produced and secreted as procollagen, which
consists of large extra domains known as the procollagen
propeptides. After secretion procollagen is converted to
collagen by specific enzymes, the endopeptidases procol-
lagen N- and C-proteinases [35]. The collagen molecules
thus formed assemble into collagen fibrils. It has been
generally assumed that these procollagen propeptides,
thus released to the extracellular space, would rapidly be
eliminated locally. While there may be some local elimi-
nation by unspecific endocytosis and degradation, there is
now ample evidence that these propeptides are trans-
ported with the lymph to the circulation and there rapidly
eliminated by efficient uptake in LSEC [20]. In vivo and in
vitro studies in rat have shown that PINP and PIIINP are
endocytosed via the SEC HA/S-R [14,42]. Both PINP and
PIIINP contain clusters of phosphate groups, and it is
likely that these highly negatively charged groups are rec-
ognized by the HA/S-R. The body produces several grams
of collagen per day. Knowing that one PINP molecule is
released per collagen type I molecule that is deposited in
the connective tissue, it is evident that the LSEC must have
a high capacity to eliminate these collagenous molecules
effectively from the circulation. Elimination of the carbox-
yterminal propeptide of type I procollagen is dealt with
under the MANN-R (see above).
ii) Atherogenic molecules: oxidized LDL (oxLDL) and advanced 
glycation end products (AGEs)
Oxidatively modified low density lipoprotein (OxLDL)
has been held as a factor that may trigger the development
of atherosclerosis. Recently advanced glycation end prod-
ucts (AGEs) have also been suggested as an atherogenic
substance [48]. Both OxLDL and AGEs are removed from
the circulation by SR-mediated endocytosis in KC and
SEC [49,50]. AGE-modified albumin (AGE-BSA) exists in
a wide spectrum of molecular sizes, spanning from the
smallest (monomers, the size of BSA) and up to highly
aggregated polymers. Intravenous administration of AGE-
BSA following separation of the molecules into high and
low Mw fractions, showed that the highly aggregated
AGE-BSA was taken up preferentially in KC, whereas the
low Mw specimens were eliminated largely by LSEC [13].
This distribution according to degree of aggregation is
compatible with the general share of work between the
two cell types, the KC taking up highly aggregated mate-
rial, and SEC being specialized to take up soluble mate-
rial. Due to the fact that OxLDL like AGEs represent a
rather heterogeneously sized group of molecules, it would
be of interest to see if high and low molecular size aggre-
gates of OxLDL distribute in the two types of sinusoidal
liver cells in the same way as was observed with high and
low molecular size AGE-BSA.
It was recently shown that endocytosis of AGEs leads to
depletion of the SR that is responsible for clearance of
AGE, namely HA/S-R [51]. In this way AGE downregulates
its own removal from the circulation. Since OxLDL is
probably also taken up in LSEC via the same HA/S-R, it
may be speculated that one of the serious pathogenic
effects of AGE may be its tendency to lower its removal,Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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with the consequence that the blood concentration of
these and other atherogenic molecules may increase, thus
increasing the risk of developing atherosclerosis and other
vascular complications.
iii) Coagulation products
Serum, but not native blood plasma, contains significant
amounts of material that is eliminated by the LSEC SR
[52]. This shows that blood coagulation in the presence of
platelets generates numerous waste macromolecules that
are readily eliminated from the circulation by receptor-
mediated endocytosis in LSEC. Although these coagula-
tion waste products have not yet been characterized, it has
been shown that they represent molecules of a large spec-
trum of molecular size, and carry a high net negative
charge. On this basis it may be speculated that they repre-
sent coagulation factors and other blood proteins that
have been tagged with negative charges by platelet-medi-
ated phosphorylation. Based on the notion that LSEC rep-
resent an important site of elimination of atherogenic
molecules, any mechanism that attenuates this activity of
LSEC should be viewed as a potentially pro-atherogenic
mechanism. Thus, in individuals with a constant activa-
tion of platelets – as in diabetic patients [53] – it is possi-
ble that the increased load of coagulation-waste products
compete with the normal scavenging of atherogenic mol-
ecules such as oxLDL and AGE.
Fc-gamma receptor (FcgR)
FcgRs recognize the Fc domain of immunoglobulin G
(IgG). These receptors can mediate phagocytosis of large
IgG coated particles and pinocytosis of soluble IgG
immune complexes. Combined Northern analysis and
RT-PCR-studies have shown that KC and LSEC express the
three FcgRs FcgRIII, FcgRIIB1 and FcgRIIB2 [54]. Blood-
borne IgG-immune complexes are taken up almost exclu-
sively in liver, both in KC and LSEC [55,56]. Although IgG
immune complexes are removed from the blood predom-
inantly by KC, it has been shown that following KC deple-
tion these immune complexes become strongly associated
with LSEC [57]. Cultured KC and LSEC both avidly bind
IgG-coated erythrocytes [15]. Since soluble IgG complexes
could compete with this binding it was concluded that
both cell types bind IgG-coated red cells specifically via
FcgRs. In contrast to LSEC, only KC internalized the
bound red cells, reflecting the general principle that KC
perform phagocytosis of particles >1 micrometer, whereas
LSEC internalize only nm size colloids or truly soluble
macromolecules.
Other Functions Related to SEC Scavenger 
Activity
Interaction of SEC with virus
It has long been known that SEC of mammalian liver rep-
resent an important site of uptake of blood-borne virus,
for instance hepatitis virus type 3 in mice, FIV (Feline
Immunodeficiency Virus) in cats, and HIV-1 (Human
Immunodeficiency Virus type 1) in humans [58-62]. If the
virus is sorted intracellularly through a route to avoid deg-
radation in the endosome/lysosome apparatus, it may
survive for a long time inside SEC, and/or be transferred
to neighbouring hepatocytes and bring about infection
and replication there. Recently, experiments with duck
hepatitis B virus, which replicates exclusively in hepato-
cytes, showed that this virus is first endocytosed by LSEC,
rescued from the endosomal/lysosomal route and then
transferred to the hepatocytes [63].
Regulation of endocytosis in SEC
A few studies have addressed the regulatory effect of
inflammatory mediators on endocytosis in SEC. Martinez
et al. [64] found that tumor necrosis factor-alpha and
interleukin-1 beta (IL-1) enhance 2–3-fold endocytosis
via the SR and MAN-R, while COLLA-R mediated endocy-
tosis remained unaffected. Lipopolysaccharide was found
to increase endocytosis in LSEC indirectly, by stimulating
the cells to release autocrine IL-1. Another mediator, nitric
oxide decrease endocytosis via the MAN-R in LSEC [65].
Using IL-10, Knolle et al. [66] found a similar effect as that
reported with nitric oxide, namely down-regulation of
MAN-R mediated endocytosis in SEC.
Role of SEC in innate and specific immunity
SEC remove not only physiological waste products from
the general circulation; material absorbed from the gut,
including virus, lipopolysaccharide and other foreign and
pathogenic substances, are also efficiently eliminated by
these cells [3]. This unique ability to endocytose practi-
cally all physiological and foreign blood-borne, soluble
waste macromolecules shows that these cells are indeed
an important part of the vertebrate innate immune sys-
tem. It was recently found that LSEC constitutively express
all molecules necessary for antigen presentation: CD54,
CD80, CD86, MHC class I and II, and CD40, and can
function as antigen-presenting cells for CD4+ and CD8+ T
cells [67,68]. In this way LSEC function as an organ-resi-
dent antigen-presenting cell inducing local specific toler-
ance in the liver towards soluble blood-borne antigens.
Thus LSEC-mediated immune tolerance of liver resides in
two unique features of this cell type: i) a scavenger func-
tion that removes blood-borne antigens quantitatively by
very active endocytosis, and ii) an antigen-presenting
activity that induces immune tolerance in CD4+ and CD8+
T cells.
Role of SEC in liver transplantation and bioartificial liver 
(BAL)
It is now generally accepted that graft rejection in liver
transplantation is often due to malfunctioning LSEC [69].
Donor liver is very sensitive to the reperfusion insultsComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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associated with KC activation and production of reactive
oxygen radicals, which attack SEC [70,71]. Consistent rise
in blood HA is a clear sign that the graft will be rejected
[72], supporting the idea that damage to LSEC precedes
rejection of grafted liver. Acute liver failure is associated
with 40–60% mortality, and transplantation is frequently
the only treatment that can save the patient. A bioartificial
liver (BAL) to keep the patient alive until a donor liver is
available, has recently been introduced. The most com-
monly used BAL consists of isolated pig hepatocytes. Liver
transplantation and BAL are often studied in pig models.
Based on what we presently know about the function of
LSEC, it is surprising that all BAL studies so far have dealt
with BALs that are made up of hepatocytes only. Moreo-
ver, it is a puzzling fact that no publications have so far
dealt with the scavenger function of liver in pig. Although
one may guess that SEC of pig liver carry out the same
scavenger functions as the corresponding cells in rats, it
remains to be shown. Two papers presented at this meet-
ing (by Geir Ivar Nedredal and Kjetil Elvevold) show that
SEC of pig liver perform the same scavenger function as
SEC in rat liver. This is important knowledge for any lab-
oratory that is engaged in BAL, and shows that a BAL that
comprises only hepatocytes does not have the ability to
remove waste macromolecules from the circulation. In
conclusion: A complete, functional BAL depends on the
presence of intact SEC. Of note, KC should be avoided
from BAL, since those cells are easily activated to produce
cytotoxic oxygen radicals that are very harmful to SEC
[70,71]
SEC and energy production
The final degradation products released from both mam-
malian and fish SEC after endocytosis of HA and CS
labeled with 14C in the carbon atoms of the pyranose rings
or with 3H in the acetyl groups have been identified as
14C-lactate and 3H-acetate [40,73]. These findings, along
with the fact that these cells contain few mitochondria,
suggest that vertebrate SEC have a largely anaerobic type
of metabolism. Recent research in our laboratory shows
that SEC produce large amounts of lactate and in this way
may supply neighbouring energy-consuming cells with
energy rich fuels such as lactate. This opens up for the pos-
sibility that SEC represent local power plants that produce
high octane fuel.
Conclusions
In this review on SEC I have focussed on the function that
is most typically associated with these cells, namely their
scavenger function. It is now clear that SEC of vertebrates
carry out many of the uptake functions that had previ-
ously been incorrectly ascribed to macrophages. As a con-
sequence the concept and functional significance of RES
have been reborn. It is now appreciated that the hepatic
RES of mammalia consists of two different cell popula-
tions, namely LSEC that eliminate soluble waste colloids
and macromolecules, and KC that remove insoluble par-
ticles of greater-than colloid size. In all vertebrates the
same share of work exists between SEC and macrophages.
Studies in phylogenetically distant vertebrate species
show that 3 functionally different endocytosis receptors
are present in SEC: the COLLA-R, the MAN-R, and the HA/
S-R. In addition LSEC of mammals express FcgR. With
these few receptors SEC eliminate a large number of
blood-borne colloidal and soluble waste macromolecules
that enter the liver both from the general circulation and
the gut. It is conceivable that SEC play a major role in
keeping the blood free of any type of macromolecular
waste. While it is obvious that this property of SEC is
highly advantageous to maintain a physiological macro-
molecular composition of blood, the cells represent a
major problem in drug targeting whenever an i.v. admin-
istered macromolecular drug is intended to reach a tissue
different than the liver. That is, if the goal is to target the
SEC proper, it will be an easy task to develop a carrier sys-
tem, since almost any modification of native proteins will
make them a ligand for SEC endocytosis receptors. How-
ever, if the goal is to target a drug to an extrahepatic target,
it takes great skill to design the drug and its vehicle in such
a way that it is not recognized by the powerful uptake sys-
tem in LSEC.
Recent research in our laboratory has shown that verte-
brate SEC run a largely anaerobic metabolism. The cells
carry few mitochondria, are exposed to blood of low oxy-
gen tension, and generate large amounts of lactate, that
may be utilized by neighbouring high energy consuming
epithelial cells as fuel for efficient production of ATP.
How important is the scavenger function of SEC for the
maintenance of normal physiology in mammals? Can we
survive without LSEC? Probably not. The fact is that these
cells are utterly important for the liver integrity; the liver
would soon stop functioning without them. This can be
illustrated by the following three examples: i) Ricin, a
highly toxic substance that is removed from the circula-
tion mainly by MAN-R mediated endocytosis in SEC [74],
destroys the SEC specifically. About 72 h following i.v.
administration of ricin, rats die due to severe liver failure.
In comparison, depletion of KC leaves the liver apparently
fully intact. ii) A transplanted liver will be rejected if the
SEC are damaged [71]. On the other hand, if KC are
depleted from the donor liver, it increases the chances that
the transplanted liver will not be rejected. iii) The mecha-
nism of acetaminophen (paracetamol) liver intoxication
resides in the effect of this drug on LSEC [75]: Experiments
in mice revealed that massive injury to SEC and thereby
disrupted the microcirculation of liver preceded develop-
ment of liver failure [76].Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S22
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Research over the past 20–30 years on the endothelial cell
that comprises the wall of the mammalian liver sinusoid
has revealed that these cells represent a far more impor-
tant part of the liver than just forming the wall of the sinu-
soids. New knowledge about the functions of these cells
leave no doubt that they represent a functional part of
liver that we cannot do without. The cells remove an array
of waste macromolecules, including virus from the blood.
Recent evidence suggests that this scavenger function is
uniquely coupled to production of lactate which supplies
the hepatocytes with high octane fuel. It is also evident
that the cells represent a dendritic-like type of cells that
present antigen to invoke specific immune tolerance.
Recent research shows that mammalian LSEC represent a
member of the vertebrate SEC system, which together
with macrophages comprise the backbone of the verte-
brate RES. It is time to realize that liver biology cannot be
understood without the knowledge of the physiological
function of LSEC.
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